Xsto, Kappa launch vitamin K2

Xsto, Kappa launch vitamin K2

Kappa Bioscience has produced a new double-coated, microencapsulated vitamin K2 as MK 7, the first and only in the market.

Xsto Solutions’ manufacturing partner Kappa Bioscience AS recently announced that it has produced a new double-coated, microencapsulated vitamin K2 as MK 7, the first and only in the market. The launch of K2VITAL Delta will take place to the U.S. market at SupplySide West 2013 at the Xsto Solutions booth #30042 November 15th and 16th at the Venetian, Sands Expo Hall. 

The new product, K2VITAL Delta, will be a follow up to the very successful 2010 launch of K2Vital by Xsto Solutions and will fill a stability gap in manufacturing left when formulating using K2 MK 7 in calcium and other mineral formulations. 

“Xsto’s exclusive North American distribution of K2VITAL Delta will give manufacturers and marketing companies a significantly better option to expand the use of vitamin K2 MK 7 in Calcium/Mineral combination products while ensuring label claims and lowering overages. It shows Kappa’s and Xsto’s continued commitment to the rapidly growing vitamin K2 market,” stated Dan Murray, Xsto’s vice president of business development.

Please visit Xsto Solutions at booth 30042 at SupplySide West or contact us at [email protected], Ph: 973-975-4224.              

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish